BIOL - BIOLASE, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Foothill Ranch,
United States
Type: Equity
BIOL price evolution
BIOL
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $6.39 | $6.57 | $7.81 | $6.93 |
| Short term investments | ||||
| Net receivables | $5.69 | $5.48 | $4.39 | $5.72 |
| Inventory | $11.27 | $11.43 | $13.82 | $13.33 |
| Total current assets | $25 | $24.86 | $27.78 | $28.15 |
| Long term investments | ||||
| Property, plant & equipment | $6.16 | $7.04 | $7.77 | $8.28 |
| Goodwill & intangible assets | $2.93 | $2.93 | $2.93 | $2.93 |
| Total noncurrent assets | $9.35 | $10.24 | $10.96 | $11.49 |
| Total investments | ||||
| Total assets | $34.35 | $35.1 | $38.74 | $39.63 |
| Current liabilities | ||||
| Accounts payable | $4.92 | $6.07 | $7.18 | $6.31 |
| Deferred revenue | $2.57 | $2.71 | $2.43 | $2.55 |
| Short long term debt | $2.8 | $2.27 | $2.8 | $2.1 |
| Total current liabilities | $21.43 | $19.66 | $19.78 | $18.38 |
| Long term debt | $11.75 | $12.55 | $12.3 | $13.12 |
| Total noncurrent liabilities | $12.66 | $13.48 | $13.08 | $13.91 |
| Total debt | $14.55 | $14.82 | $15.1 | $15.22 |
| Total liabilities | $34.08 | $33.15 | $32.86 | $32.29 |
| Shareholders' equity | ||||
| Retained earnings | -$323.29 | -$316.8 | -$311.47 | -$306.88 |
| Other shareholder equity | -$0.64 | -$0.55 | -$0.72 | -$0.61 |
| Total shareholder equity | -$1.93 | -$0.25 | $0.33 | $6.62 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $6.57 | $4.18 | $30.18 | $17.88 |
| Short term investments | ||||
| Net receivables | $5.48 | $5.84 | $4.24 | $3.06 |
| Inventory | $11.43 | $15.88 | $12.93 | $11.16 |
| Total current assets | $24.86 | $28.96 | $49.35 | $35.11 |
| Long term investments | ||||
| Property, plant & equipment | $7.04 | $6.05 | $2.78 | $2.76 |
| Goodwill & intangible assets | $2.93 | $2.93 | $2.93 | $2.93 |
| Total noncurrent assets | $10.24 | $9.23 | $5.93 | $5.92 |
| Total investments | ||||
| Total assets | $35.1 | $38.19 | $55.28 | $41.02 |
| Current liabilities | ||||
| Accounts payable | $6.07 | $5.79 | $3.31 | $2.65 |
| Deferred revenue | $2.71 | $2.53 | $2.59 | $2.28 |
| Short long term debt | $2.27 | $0.7 | ||
| Total current liabilities | $19.66 | $17.81 | $13.84 | $11.22 |
| Long term debt | $12.55 | $13.09 | $15.05 | $17.96 |
| Total noncurrent liabilities | $13.48 | $15.49 | $16.23 | $19.77 |
| Total debt | $14.82 | $15.05 | $15.05 | $17.96 |
| Total liabilities | $33.15 | $33.3 | $30.08 | $31 |
| Shareholders' equity | ||||
| Retained earnings | -$316.8 | -$296.17 | -$267.53 | -$251.38 |
| Other shareholder equity | -$0.55 | -$0.73 | -$0.62 | -$0.39 |
| Total shareholder equity | -$0.25 | $4.89 | $25.21 | $10.03 |
| (in millions $) | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $10.13 | $13.49 | $10.92 | |
| Cost of revenue | $6.79 | $9.97 | $7.17 | |
| Gross Profit | $3.34 | $3.52 | $3.75 | |
| Operating activities | ||||
| Research & development | $1.28 | $1.65 | $1.36 | |
| Selling, general & administrative | $6.58 | $6.95 | $6.08 | |
| Total operating expenses | $7.86 | $8.6 | $7.44 | |
| Operating income | -$4.53 | -$5.08 | -$3.7 | |
| Income from continuing operations | ||||
| EBIT | -$5.84 | -$4.74 | -$3.98 | |
| Income tax expense | $0.02 | -$0.01 | $0.01 | |
| Interest expense | $0.62 | $0.6 | $0.6 | |
| Net income | ||||
| Net income | -$6.49 | -$5.33 | -$4.59 | |
| Income (for common shares) | -$6.49 | -$22.31 | -$4.59 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $49.16 | $48.46 | $39.19 | $22.78 |
| Cost of revenue | $32.44 | $32.55 | $22.66 | $16.61 |
| Gross Profit | $16.72 | $15.91 | $16.53 | $6.17 |
| Operating activities | ||||
| Research & development | $6 | $7.26 | $6.05 | $3.69 |
| Selling, general & administrative | $28.66 | $33.98 | $26.6 | $21.01 |
| Total operating expenses | $34.66 | $41.25 | $32.96 | $24.71 |
| Operating income | -$17.94 | -$25.34 | -$16.43 | -$18.54 |
| Income from continuing operations | ||||
| EBIT | -$18.24 | -$25.78 | -$13.87 | -$14.34 |
| Income tax expense | $0.03 | $0.11 | $0.07 | $0.13 |
| Interest expense | $2.36 | $2.75 | $2.22 | $2.36 |
| Net income | ||||
| Net income | -$20.63 | -$28.63 | -$16.16 | -$16.83 |
| Income (for common shares) | -$37.62 | -$28.85 | -$16.16 | -$16.83 |
| (in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Net income | -$6.49 | -$5.33 | -$4.59 | -$4.87 |
| Operating activities | ||||
| Depreciation | $0.66 | $0.67 | $0.56 | $1.42 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.11 | $0.18 | $0.28 | $0.08 |
| Total cash flows from operations | -$5.94 | -$2.28 | -$2.59 | -$3.56 |
| Investing activities | ||||
| Capital expenditures | $0.2 | -$0 | -$0.18 | -$0.36 |
| Investments | ||||
| Total cash flows from investing | $0.2 | -$0 | -$0.18 | -$0.36 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.79 | $1.05 | -$0.52 | $0.62 |
| Net borrowings | -$0.17 | -$0.17 | ||
| Total cash flows from financing | $5.65 | $0.89 | $3.76 | $4.28 |
| Effect of exchange rate | -$0.08 | $0.16 | -$0.11 | $0.04 |
| Change in cash and equivalents | -$0.17 | -$1.24 | $0.88 | $0.4 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$20.63 | -$28.63 | -$16.16 | -$16.83 |
| Operating activities | ||||
| Depreciation | $2.8 | $0.5 | $0.4 | $0.5 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.23 | $2.41 | $1.83 | $3.37 |
| Total cash flows from operations | -$14.09 | -$26.76 | -$16.71 | -$12.79 |
| Investing activities | ||||
| Capital expenditures | -$1.13 | -$3.73 | -$0.71 | -$0.1 |
| Investments | ||||
| Total cash flows from investing | -$1.13 | -$3.73 | -$0.71 | -$0.1 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $9.67 | $5.6 | $29.98 | $5.68 |
| Net borrowings | -$0.17 | -$1 | -$0.03 | $2.31 |
| Total cash flows from financing | $17.43 | $4.6 | $29.95 | $24.35 |
| Effect of exchange rate | $0.17 | -$0.11 | -$0.24 | $0.32 |
| Change in cash and equivalents | $2.38 | -$25.99 | $12.3 | $11.78 |
News
Fundamentals
| Market cap | $412.39K |
|---|---|
| Enterprise value | $8.57M |
| Shares outstanding | 33.26M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | -0.32 |
| Book/Share | -0.04 |
| Cash/Share | 0.19 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | -134.19 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.17 |
| Quick ratio | 0.64 |